Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenazine is roughly five times as potent as chlorpromazine, thus perphenazine is considered a medium-potency antipsychotic.
The global Perphenazine market size was valued at US$ 104 million in 2023 and is forecast to a readjusted size of USD 130 million by 2030 with a CAGR of 3.2% during review period.
Global Perphenazine key players include Teva, Sandoz, Endo, Mylan, ZHPHARMA etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Asia-Pacific and Europe, both have a share over 20% percent.
In terms of product, Oral Forms is the largest segment, with a share over 90%. And in terms of application, the largest application is Psychosis followed by Antiemetic.
This report is a detailed and comprehensive analysis for global Perphenazine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Perphenazine market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2019-2030
Global Perphenazine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2019-2030
Global Perphenazine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2019-2030
Global Perphenazine market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Perphenazine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Perphenazine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Sandoz, Endo, Mylan, ZHPHARMA, Shandong Boshan Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Perphenazine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Oral Forms
Injectable Solution
麻豆原创 segment by Application
Psychosis
Antiemetic
Major players covered
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Perphenazine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Perphenazine, with price, sales quantity, revenue, and global market share of Perphenazine from 2019 to 2024.
Chapter 3, the Perphenazine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Perphenazine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Perphenazine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Perphenazine.
Chapter 14 and 15, to describe Perphenazine sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Perphenazine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oral Forms
1.3.3 Injectable Solution
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Perphenazine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Psychosis
1.4.3 Antiemetic
1.5 Global Perphenazine 麻豆原创 Size & Forecast
1.5.1 Global Perphenazine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Perphenazine Sales Quantity (2019-2030)
1.5.3 Global Perphenazine Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Perphenazine Product and Services
2.1.4 Teva Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Teva Recent Developments/Updates
2.2 Sandoz
2.2.1 Sandoz Details
2.2.2 Sandoz Major Business
2.2.3 Sandoz Perphenazine Product and Services
2.2.4 Sandoz Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Sandoz Recent Developments/Updates
2.3 Endo
2.3.1 Endo Details
2.3.2 Endo Major Business
2.3.3 Endo Perphenazine Product and Services
2.3.4 Endo Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Endo Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Perphenazine Product and Services
2.4.4 Mylan Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Mylan Recent Developments/Updates
2.5 ZHPHARMA
2.5.1 ZHPHARMA Details
2.5.2 ZHPHARMA Major Business
2.5.3 ZHPHARMA Perphenazine Product and Services
2.5.4 ZHPHARMA Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 ZHPHARMA Recent Developments/Updates
2.6 Shandong Boshan Pharma
2.6.1 Shandong Boshan Pharma Details
2.6.2 Shandong Boshan Pharma Major Business
2.6.3 Shandong Boshan Pharma Perphenazine Product and Services
2.6.4 Shandong Boshan Pharma Perphenazine Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Shandong Boshan Pharma Recent Developments/Updates
3 Competitive Environment: Perphenazine by Manufacturer
3.1 Global Perphenazine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Perphenazine Revenue by Manufacturer (2019-2024)
3.3 Global Perphenazine Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Perphenazine by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Perphenazine Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Perphenazine Manufacturer 麻豆原创 Share in 2023
3.5 Perphenazine 麻豆原创: Overall Company Footprint Analysis
3.5.1 Perphenazine 麻豆原创: Region Footprint
3.5.2 Perphenazine 麻豆原创: Company Product Type Footprint
3.5.3 Perphenazine 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Perphenazine 麻豆原创 Size by Region
4.1.1 Global Perphenazine Sales Quantity by Region (2019-2030)
4.1.2 Global Perphenazine Consumption Value by Region (2019-2030)
4.1.3 Global Perphenazine Average Price by Region (2019-2030)
4.2 North America Perphenazine Consumption Value (2019-2030)
4.3 Europe Perphenazine Consumption Value (2019-2030)
4.4 Asia-Pacific Perphenazine Consumption Value (2019-2030)
4.5 South America Perphenazine Consumption Value (2019-2030)
4.6 Middle East & Africa Perphenazine Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Perphenazine Sales Quantity by Type (2019-2030)
5.2 Global Perphenazine Consumption Value by Type (2019-2030)
5.3 Global Perphenazine Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Perphenazine Sales Quantity by Application (2019-2030)
6.2 Global Perphenazine Consumption Value by Application (2019-2030)
6.3 Global Perphenazine Average Price by Application (2019-2030)
7 North America
7.1 North America Perphenazine Sales Quantity by Type (2019-2030)
7.2 North America Perphenazine Sales Quantity by Application (2019-2030)
7.3 North America Perphenazine 麻豆原创 Size by Country
7.3.1 North America Perphenazine Sales Quantity by Country (2019-2030)
7.3.2 North America Perphenazine Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Perphenazine Sales Quantity by Type (2019-2030)
8.2 Europe Perphenazine Sales Quantity by Application (2019-2030)
8.3 Europe Perphenazine 麻豆原创 Size by Country
8.3.1 Europe Perphenazine Sales Quantity by Country (2019-2030)
8.3.2 Europe Perphenazine Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Perphenazine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Perphenazine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Perphenazine 麻豆原创 Size by Region
9.3.1 Asia-Pacific Perphenazine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Perphenazine Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Perphenazine Sales Quantity by Type (2019-2030)
10.2 South America Perphenazine Sales Quantity by Application (2019-2030)
10.3 South America Perphenazine 麻豆原创 Size by Country
10.3.1 South America Perphenazine Sales Quantity by Country (2019-2030)
10.3.2 South America Perphenazine Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Perphenazine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Perphenazine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Perphenazine 麻豆原创 Size by Country
11.3.1 Middle East & Africa Perphenazine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Perphenazine Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Perphenazine 麻豆原创 Drivers
12.2 Perphenazine 麻豆原创 Restraints
12.3 Perphenazine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Perphenazine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Perphenazine
13.3 Perphenazine Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Perphenazine Typical Distributors
14.3 Perphenazine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Teva
Sandoz
Endo
Mylan
ZHPHARMA
Shandong Boshan Pharma
听
听
*If Applicable.
